Reports
Sale
Global Stents Market Size, Share, Trends, Growth, Analysis: By Product Type: Coronary Stents, Peripheral Stents, Neurovascular Stents, Stent-Related Implants; By Type: Self-Expandable Stents, Balloon-Expandable Stents; By Material: Metallic Stents, Polymer Stents, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Stents Market Outlook
The global stents market size was valued at USD 12.5 billion in 2023, driven by rising prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 5.6% during the forecast period of 2024-2032, with the values likely to reach USD 20.4 billion by 2032.
Global Stents Market Overview
A stent is a small, expandable tube that a doctor inserts into a blocked passageway to keep it open. Stents are made of either metal or plastic and are often used to treat narrowed coronary arteries that provide the heart with oxygen-rich blood. Stents can help relieve blockages and treat narrow or weakened arteries. Stents are inserted during an angioplasty procedure.
The market demand for stents is based on the growing focus on patient-centric approaches in stent design and development such as stents designed for improved patient comfort, reduced complications, and enhancing long-term outcomes. This shift towards patient-centered care aligns with the emphasis on delivering more personalized and effective treatments while boosting the market.
Rising Burden of Cardiovascular Diseases to be the Primary Driver
The stents market demand is driven by the increasing incidence of cardiovascular diseases. More than half of the world’s population is affected by cardiovascular diseases with the mortalities expected to reach 121 million deaths in the forecast period. Around 4 in every 5 cardiovascular deaths occur in low- and middle-income countries, out of which around 80% of premature heart attacks and strokes can be prevented. The growing prevalence of cardiovascular diseases can be attributed to increased tobacco and alcohol consumption, sedentary lifestyle, and high obesity rates.
New Product Launches to Propel the Growth of the Market
Industry leaders are continuously developing and introducing new stent technologies that offer enhanced performance, improved deliverability, and better patient outcomes. These innovations are reshaping the landscape of cardiovascular care by providing more effective solutions for complex cases and further escalating the global stents market growth. In December 2023, Terumo India launched Ultimaster Nagomi™, a Drug-Eluting Stent intended to treat the rising cases of coronary heart disease in the region. The latest design is expected to facilitate better access to complex arteries with an optimal design, expanded size ranges and improved overexpansion capabilities.
Surge in Merger and Acquisition Activity to Aid the Market Development
A surge in the global stents market share is driven by the increasing number of mergers and acquisitions among prominent players in the industry. For instance, in February 2023, Olympus Corporation acquired Korea based Taewoong Medical Co., Ltd to strengthen their GI EndoTherapy product portfolio. The acquisition was valued at USD 114.5 million, offering comprehensive solutions to improve patient outcomes. A leader in GI stents, Taewoong Medical offers a diverse range of metallic stents for biliary tract, esophagus, colon, and duodenum treatments. The agreement will help Olympus build a full portfolio of clinically differentiated techniques.
Innovation in Design and Material to Drive the Market Growth
In May 2023, Shockwave Medical, Inc., launched their latest Shockwave C2+ coronary intravascular lithotripsy (IVL) catheter for the treatment of severely calcified de novo coronary arteries. The new technology is revolutionizing stent effectiveness, particularly for severe and life-threatening coronary artery blockages by employing sonic waves to disintegrate hard, calcified plaque within arteries, presenting a promising avenue for enhancing patient outcomes.
The stents market size is also witnessing a wave of innovation with the introduction of new products by key industry players. For example, Medtronic's launch of the Onyx Frontier™ drug-eluting stent, following CE Mark approval, showcases this trend. The Onyx Frontier DES offers improved deliverability and acute performance, building upon the success of its predecessor, the Resolute Onyx™ drug-eluting stent. Such product launches contribute to the continuous advancement of cardiovascular care, further fostering the market growth.
Global Stents Market Segmentation
Market Breakup by Product Type
- Coronary Stents
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
- Peripheral Stents
- Iliac Stent
- Femoral-Popliteal Stents
- Renal and Related Stents
- Carotid Stents
- Neurovascular Stents
- Stent-Related Implants
- Synthetic Grafts
- Vena Cava Filters
Market Breakup by Type
- Self-Expandable Stents
- Balloon-Expandable Stents
Market Breakup by Material
- Metallic Stents
- Polymer Stents
- Bioresorbable Stents
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Stents Market Regional Analysis
The United States is expected to lead the global market owing to the presence of a robust healthcare infrastructure and the presence of key healthcare companies along with research institutions. The rising prevalence of cardiovascular diseases due to dynamic lifestyle changes can be attributed as a major factor for the market share. Regulatory advancements and approvals are influencing stents market growth in the region. Regulatory agencies are continuously evaluating and approving new stent technologies, ensuring their safety and efficacy. These approvals open new opportunities for stent manufacturers to introduce their products to a wider market. Moreover, there has been a notable upswing in merger and acquisition activity among key leaders, which is expected to boost the stents market positively in upcoming years.
Global Stents Market: Competitor Landscape
In February 2023, Abbott acquired Cardiovascular Systems, Inc. to expand their vascular devices portfolio and offer improved solutions for peripheral and coronary heart diseases. The acquisition is expected to cost around USD 890 million, with a vision to leverage Cardiovascular Systems’ pioneering atherectomy system to facilitate more tools to physicians. Such trends aim to benefit from the expertise of different companies to develop comprehensive solutions and expand the market. These partnerships enhance the capabilities of stent manufacturers, resulting in the availability of a wider range of options for healthcare providers and patients.
The key features of the stents market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Boston Scientific Corporation
- BD
- Medtronic
- Abbott
- Cook Medical
- Merit Medical Systems
- Novatech SA
- Terumo Corporation
- MicroPort Scientific Corporation
- Fuji Systems Corp.
- MICRO-TECH EUROPE
- Vascular Concepts
- Olympus Corporation
- W. L. Gore & Associates Inc.
- B. Braun Melsungen AG
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Material |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stents Market Overview
3.1 Global Stents Market Historical Value (2017-2023)
3.2 Global Stents Market Forecast Value (2024-2032)
4 Global Stents Market Landscape
4.1 Global Stents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stents Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stents Market Segmentation
6.1 Global Stents Market by Product Type
6.1.1 Market Overview
6.1.2 Coronary Stents
6.1.2.1 Drug-Eluting Stents (DES)
6.1.2.2 Bare-Metal Coronary Stents
6.1.2.3 Bioabsorbable Stents
6.1.3 Peripheral Stents
6.1.3.1 Iliac Stent
6.1.3.2 Femoral-Popliteal Stents
6.1.3.3 Renal and Related Stents
6.1.3.4 Carotid Stents
6.1.4 Neurovascular Stents
6.1.5 Stent-Related Implants
6.1.5.1 Synthetic Grafts
6.1.5.2 Vena Cava Filters
6.2 Global Stents Market by Type
6.2.1 Market Overview
6.2.2 Self-Expandable Stents
6.2.3 Balloon-Expandable Stents
6.3 Global Stents Market by Material
6.3.1 Market Overview
6.3.2 Metallic Stents
6.3.3 Polymer Stents
6.3.4 Bioresorbable Stents
6.3.5 Others
6.4 Global Stents Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centres
6.4.4 Others
6.5 Global Stents Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Stents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Stents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Stents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Stents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Stents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 BD
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Abbott
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Cook Medical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Merit Medical Systems
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Novatech SA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Terumo Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 MicroPort Scientific Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Fuji Systems Corp.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 MICRO-TECH EUROPE
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Vascular Concepts
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Olympus Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 W. L. Gore & Associates Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 B. Braun Melsungen AG
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Stents Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 12.5 billion in 2023, driven by the growing prevalence of cardiovascular diseases across the globe.
The market is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032, likely to reach a market value of USD 20.4 billion by 2032.
The market demand is driven by the improvement in stent design and technologies to offer improved solutions to the patients. In addition, rising regulatory approvals along with investments in the healthcare industry are impacting the market demand significantly.
Increasing strategic collaborations and partnerships between key players is a major trend influencing market growth. In February 2023, Olympus Corporation acquired Korea based Taewoong Medical Co., Ltd, to strengthen their GI EndoTherapy product portfolio in a USD 114.5 million deal.
Based on product types, the market is divided into coronary stents, peripheral stents, neurovascular stents, and stent-related implants.
It is divided into self-expandable stents and balloon-expandable stents.
They include metallic stents, polymer stents, and bioresorbable stents, among others.
Major end users include hospitals, clinics, ambulatory surgical centers, and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Boston Scientific Corporation, BD, Medtronic, Abbott, Cook Medical, Merit Medical Systems, Novatech SA, Terumo Corporation, MicroPort Scientific Corporation, Fuji Systems Corp., MICRO-TECH EUROPE, Vascular Concepts, Olympus Corporation, W. L. Gore & Associates Inc., and B. Braun Melsungen AG.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER